miR-638 is a new biomarker for outcome prediction of non-small cell lung cancer patients receiving chemotherapy. [electronic resource]
Producer: 20160126Description: e162 p. digitalISSN:- 2092-6413
- Animals
- Antineoplastic Agents -- therapeutic use
- Biomarkers, Tumor -- blood
- Carcinoma, Non-Small-Cell Lung -- blood
- Cell Line, Tumor
- Cisplatin -- therapeutic use
- Female
- Gene Expression Regulation, Neoplastic -- drug effects
- Humans
- Lung -- drug effects
- Lung Neoplasms -- blood
- Male
- Mice
- Mice, Nude
- MicroRNAs -- blood
- Middle Aged
- Prognosis
- Survival Analysis
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.